▶ 調査レポート

世界の乱用薬物検査市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Drugs of Abuse Testing Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の乱用薬物検査市場規模・現状・予測(2021年-2027年) / Global Drugs of Abuse Testing Market Size, Status and Forecast 2021-2027 / QFJ1-4160資料のイメージです。• レポートコード:QFJ1-4160
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、乱用薬物検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(覚醒剤、麻薬、幻覚剤、鎮静剤、その他)、用途別市場規模(病院、診断研究所、法医学研究所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・乱用薬物検査の市場動向
・企業の競争状況、市場シェア
・乱用薬物検査の種類別市場規模と予測2016-2027(覚醒剤、麻薬、幻覚剤、鎮静剤、その他)
・乱用薬物検査の用途別市場規模と予測2016-2027(病院、診断研究所、法医学研究所、その他)
・乱用薬物検査の北米市場規模2016-2027(アメリカ、カナダ)
・乱用薬物検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・乱用薬物検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・乱用薬物検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・乱用薬物検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Quest Diagnostics、F. Hoffmann La-Roche、Siemens、Thermo Fisher Scientific、Abbott、Shimadzu、Laboratory Corporation of America)
・結論

Market Analysis and Insights: Global Drugs of Abuse Testing Market
The global Drugs of Abuse Testing market size is projected to reach US$ 3956.6 million by 2027, from US$ 2874.4 million in 2020, at a CAGR of 4.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs of Abuse Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs of Abuse Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs of Abuse Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs of Abuse Testing market.

Global Drugs of Abuse Testing Scope and Market Size
Drugs of Abuse Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs of Abuse Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Psychostimulants
Narcotic
Hallucinogens
Sedatives
Others

Segment by Application
Hospitals
Diagnostics Laboratories
Forensic Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Quest Diagnostics
F. Hoffmann La-Roche
Siemens
Thermo Fisher Scientific
Abbott
Shimadzu
Laboratory Corporation of America

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs of Abuse Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Psychostimulants
1.2.3 Narcotic
1.2.4 Hallucinogens
1.2.5 Sedatives
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drugs of Abuse Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Forensic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drugs of Abuse Testing Market Perspective (2016-2027)
2.2 Drugs of Abuse Testing Growth Trends by Regions
2.2.1 Drugs of Abuse Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs of Abuse Testing Historic Market Share by Regions (2016-2021)
2.2.3 Drugs of Abuse Testing Forecasted Market Size by Regions (2022-2027)
2.3 Drugs of Abuse Testing Industry Dynamic
2.3.1 Drugs of Abuse Testing Market Trends
2.3.2 Drugs of Abuse Testing Market Drivers
2.3.3 Drugs of Abuse Testing Market Challenges
2.3.4 Drugs of Abuse Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drugs of Abuse Testing Players by Revenue
3.1.1 Global Top Drugs of Abuse Testing Players by Revenue (2016-2021)
3.1.2 Global Drugs of Abuse Testing Revenue Market Share by Players (2016-2021)
3.2 Global Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs of Abuse Testing Revenue
3.4 Global Drugs of Abuse Testing Market Concentration Ratio
3.4.1 Global Drugs of Abuse Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs of Abuse Testing Revenue in 2020
3.5 Drugs of Abuse Testing Key Players Head office and Area Served
3.6 Key Players Drugs of Abuse Testing Product Solution and Service
3.7 Date of Enter into Drugs of Abuse Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs of Abuse Testing Breakdown Data by Type
4.1 Global Drugs of Abuse Testing Historic Market Size by Type (2016-2021)
4.2 Global Drugs of Abuse Testing Forecasted Market Size by Type (2022-2027)

5 Drugs of Abuse Testing Breakdown Data by Application
5.1 Global Drugs of Abuse Testing Historic Market Size by Application (2016-2021)
5.2 Global Drugs of Abuse Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drugs of Abuse Testing Market Size (2016-2027)
6.2 North America Drugs of Abuse Testing Market Size by Type
6.2.1 North America Drugs of Abuse Testing Market Size by Type (2016-2021)
6.2.2 North America Drugs of Abuse Testing Market Size by Type (2022-2027)
6.2.3 North America Drugs of Abuse Testing Market Size by Type (2016-2027)
6.3 North America Drugs of Abuse Testing Market Size by Application
6.3.1 North America Drugs of Abuse Testing Market Size by Application (2016-2021)
6.3.2 North America Drugs of Abuse Testing Market Size by Application (2022-2027)
6.3.3 North America Drugs of Abuse Testing Market Size by Application (2016-2027)
6.4 North America Drugs of Abuse Testing Market Size by Country
6.4.1 North America Drugs of Abuse Testing Market Size by Country (2016-2021)
6.4.2 North America Drugs of Abuse Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Drugs of Abuse Testing Market Size (2016-2027)
7.2 Europe Drugs of Abuse Testing Market Size by Type
7.2.1 Europe Drugs of Abuse Testing Market Size by Type (2016-2021)
7.2.2 Europe Drugs of Abuse Testing Market Size by Type (2022-2027)
7.2.3 Europe Drugs of Abuse Testing Market Size by Type (2016-2027)
7.3 Europe Drugs of Abuse Testing Market Size by Application
7.3.1 Europe Drugs of Abuse Testing Market Size by Application (2016-2021)
7.3.2 Europe Drugs of Abuse Testing Market Size by Application (2022-2027)
7.3.3 Europe Drugs of Abuse Testing Market Size by Application (2016-2027)
7.4 Europe Drugs of Abuse Testing Market Size by Country
7.4.1 Europe Drugs of Abuse Testing Market Size by Country (2016-2021)
7.4.2 Europe Drugs of Abuse Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drugs of Abuse Testing Market Size (2016-2027)
8.2 Asia-Pacific Drugs of Abuse Testing Market Size by Type
8.2.1 Asia-Pacific Drugs of Abuse Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drugs of Abuse Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drugs of Abuse Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Drugs of Abuse Testing Market Size by Application
8.3.1 Asia-Pacific Drugs of Abuse Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drugs of Abuse Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drugs of Abuse Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Drugs of Abuse Testing Market Size by Region
8.4.1 Asia-Pacific Drugs of Abuse Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drugs of Abuse Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drugs of Abuse Testing Market Size (2016-2027)
9.2 Latin America Drugs of Abuse Testing Market Size by Type
9.2.1 Latin America Drugs of Abuse Testing Market Size by Type (2016-2021)
9.2.2 Latin America Drugs of Abuse Testing Market Size by Type (2022-2027)
9.2.3 Latin America Drugs of Abuse Testing Market Size by Type (2016-2027)
9.3 Latin America Drugs of Abuse Testing Market Size by Application
9.3.1 Latin America Drugs of Abuse Testing Market Size by Application (2016-2021)
9.3.2 Latin America Drugs of Abuse Testing Market Size by Application (2022-2027)
9.3.3 Latin America Drugs of Abuse Testing Market Size by Application (2016-2027)
9.4 Latin America Drugs of Abuse Testing Market Size by Country
9.4.1 Latin America Drugs of Abuse Testing Market Size by Country (2016-2021)
9.4.2 Latin America Drugs of Abuse Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drugs of Abuse Testing Market Size (2016-2027)
10.2 Middle East & Africa Drugs of Abuse Testing Market Size by Type
10.2.1 Middle East & Africa Drugs of Abuse Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drugs of Abuse Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drugs of Abuse Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Drugs of Abuse Testing Market Size by Application
10.3.1 Middle East & Africa Drugs of Abuse Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drugs of Abuse Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drugs of Abuse Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Drugs of Abuse Testing Market Size by Country
10.4.1 Middle East & Africa Drugs of Abuse Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drugs of Abuse Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Drugs of Abuse Testing Introduction
11.1.4 Quest Diagnostics Revenue in Drugs of Abuse Testing Business (2016-2021)
11.1.5 Quest Diagnostics Recent Development
11.2 F. Hoffmann La-Roche
11.2.1 F. Hoffmann La-Roche Company Details
11.2.2 F. Hoffmann La-Roche Business Overview
11.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Introduction
11.2.4 F. Hoffmann La-Roche Revenue in Drugs of Abuse Testing Business (2016-2021)
11.2.5 F. Hoffmann La-Roche Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Drugs of Abuse Testing Introduction
11.3.4 Siemens Revenue in Drugs of Abuse Testing Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drugs of Abuse Testing Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Drugs of Abuse Testing Introduction
11.5.4 Abbott Revenue in Drugs of Abuse Testing Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Details
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Drugs of Abuse Testing Introduction
11.6.4 Shimadzu Revenue in Drugs of Abuse Testing Business (2016-2021)
11.6.5 Shimadzu Recent Development
11.7 Laboratory Corporation of America
11.7.1 Laboratory Corporation of America Company Details
11.7.2 Laboratory Corporation of America Business Overview
11.7.3 Laboratory Corporation of America Drugs of Abuse Testing Introduction
11.7.4 Laboratory Corporation of America Revenue in Drugs of Abuse Testing Business (2016-2021)
11.7.5 Laboratory Corporation of America Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Drugs of Abuse Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Psychostimulants
Table 3. Key Players of Narcotic
Table 4. Key Players of Hallucinogens
Table 5. Key Players of Sedatives
Table 6. Key Players of Others
Table 7. Global Drugs of Abuse Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drugs of Abuse Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Drugs of Abuse Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Drugs of Abuse Testing Market Share by Regions (2016-2021)
Table 11. Global Drugs of Abuse Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Drugs of Abuse Testing Market Share by Regions (2022-2027)
Table 13. Drugs of Abuse Testing Market Trends
Table 14. Drugs of Abuse Testing Market Drivers
Table 15. Drugs of Abuse Testing Market Challenges
Table 16. Drugs of Abuse Testing Market Restraints
Table 17. Global Drugs of Abuse Testing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Drugs of Abuse Testing Market Share by Players (2016-2021)
Table 19. Global Top Drugs of Abuse Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs of Abuse Testing as of 2020)
Table 20. Ranking of Global Top Drugs of Abuse Testing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Drugs of Abuse Testing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drugs of Abuse Testing Product Solution and Service
Table 24. Date of Enter into Drugs of Abuse Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs of Abuse Testing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Drugs of Abuse Testing Revenue Market Share by Type (2016-2021)
Table 28. Global Drugs of Abuse Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Drugs of Abuse Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Drugs of Abuse Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Drugs of Abuse Testing Revenue Market Share by Application (2016-2021)
Table 32. Global Drugs of Abuse Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Drugs of Abuse Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Drugs of Abuse Testing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Drugs of Abuse Testing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Drugs of Abuse Testing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Drugs of Abuse Testing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Drugs of Abuse Testing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Drugs of Abuse Testing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Drugs of Abuse Testing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Drugs of Abuse Testing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Drugs of Abuse Testing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Drugs of Abuse Testing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Drugs of Abuse Testing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Drugs of Abuse Testing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Drugs of Abuse Testing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Drugs of Abuse Testing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Drugs of Abuse Testing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Drugs of Abuse Testing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Drugs of Abuse Testing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Drugs of Abuse Testing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Drugs of Abuse Testing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Drugs of Abuse Testing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Drugs of Abuse Testing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Drugs of Abuse Testing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Drugs of Abuse Testing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Drugs of Abuse Testing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Drugs of Abuse Testing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Drugs of Abuse Testing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Drugs of Abuse Testing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Drugs of Abuse Testing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Drugs of Abuse Testing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Drugs of Abuse Testing Market Size by Country (2022-2027) & (US$ Million)
Table 64. Quest Diagnostics Company Details
Table 65. Quest Diagnostics Business Overview
Table 66. Quest Diagnostics Drugs of Abuse Testing Product
Table 67. Quest Diagnostics Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 68. Quest Diagnostics Recent Development
Table 69. F. Hoffmann La-Roche Company Details
Table 70. F. Hoffmann La-Roche Business Overview
Table 71. F. Hoffmann La-Roche Drugs of Abuse Testing Product
Table 72. F. Hoffmann La-Roche Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 73. F. Hoffmann La-Roche Recent Development
Table 74. Siemens Company Details
Table 75. Siemens Business Overview
Table 76. Siemens Drugs of Abuse Testing Product
Table 77. Siemens Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 78. Siemens Recent Development
Table 79. Thermo Fisher Scientific Company Details
Table 80. Thermo Fisher Scientific Business Overview
Table 81. Thermo Fisher Scientific Drugs of Abuse Testing Product
Table 82. Thermo Fisher Scientific Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 83. Thermo Fisher Scientific Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Drugs of Abuse Testing Product
Table 87. Abbott Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Shimadzu Company Details
Table 90. Shimadzu Business Overview
Table 91. Shimadzu Drugs of Abuse Testing Product
Table 92. Shimadzu Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 93. Shimadzu Recent Development
Table 94. Laboratory Corporation of America Company Details
Table 95. Laboratory Corporation of America Business Overview
Table 96. Laboratory Corporation of America Drugs of Abuse Testing Product
Table 97. Laboratory Corporation of America Revenue in Drugs of Abuse Testing Business (2016-2021) & (US$ Million)
Table 98. Laboratory Corporation of America Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs of Abuse Testing Market Share by Type: 2020 VS 2027
Figure 2. Psychostimulants Features
Figure 3. Narcotic Features
Figure 4. Hallucinogens Features
Figure 5. Sedatives Features
Figure 6. Others Features
Figure 7. Global Drugs of Abuse Testing Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Diagnostics Laboratories Case Studies
Figure 10. Forensic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Drugs of Abuse Testing Report Years Considered
Figure 13. Global Drugs of Abuse Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Drugs of Abuse Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Drugs of Abuse Testing Market Share by Regions: 2020 VS 2027
Figure 16. Global Drugs of Abuse Testing Market Share by Regions (2022-2027)
Figure 17. Global Drugs of Abuse Testing Market Share by Players in 2020
Figure 18. Global Top Drugs of Abuse Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs of Abuse Testing as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Drugs of Abuse Testing Revenue in 2020
Figure 20. Global Drugs of Abuse Testing Revenue Market Share by Type (2016-2021)
Figure 21. Global Drugs of Abuse Testing Revenue Market Share by Type (2022-2027)
Figure 22. North America Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Drugs of Abuse Testing Market Share by Type (2016-2027)
Figure 24. North America Drugs of Abuse Testing Market Share by Application (2016-2027)
Figure 25. North America Drugs of Abuse Testing Market Share by Country (2016-2027)
Figure 26. United States Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Drugs of Abuse Testing Market Share by Type (2016-2027)
Figure 30. Europe Drugs of Abuse Testing Market Share by Application (2016-2027)
Figure 31. Europe Drugs of Abuse Testing Market Share by Country (2016-2027)
Figure 32. Germany Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Drugs of Abuse Testing Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Drugs of Abuse Testing Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Drugs of Abuse Testing Market Share by Region (2016-2027)
Figure 42. China Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Drugs of Abuse Testing Market Share by Type (2016-2027)
Figure 50. Latin America Drugs of Abuse Testing Market Share by Application (2016-2027)
Figure 51. Latin America Drugs of Abuse Testing Market Share by Country (2016-2027)
Figure 52. Mexico Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Drugs of Abuse Testing Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Drugs of Abuse Testing Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Drugs of Abuse Testing Market Share by Country (2016-2027)
Figure 58. Turkey Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Drugs of Abuse Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Quest Diagnostics Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 62. F. Hoffmann La-Roche Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 63. Siemens Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 66. Shimadzu Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 67. Laboratory Corporation of America Revenue Growth Rate in Drugs of Abuse Testing Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed